^
NEW:
Evidence
Click below to explore the latest additions to VERI
PD-L1 expression
NSCLC
AGK-BRAF fusion
Melanoma
ERBB3 expression
Breast Cancer
BRAF V600
Thyroid Gland Anaplastic Carcinoma
MGMT unmethylation
GBM
BRAF V600
Glioma
EGFR mutation
NSCLC
HER-2 expression
Lung Cancer
BRAF V600
Ovarian Cancer
BRAF V600
Thyroid Gland Papillary Carcinoma
KRAS G12C
NSCLC
ALK positive
NSCLC
PD-L1 expression
SCCHN
FOLR1 expression
Ovarian Cancer
HR positive
HER2 Negative Breast Cancer
RSPO3 fusion
GIST
HER-2 positive
HER2 Positive Breast Cancer
IDH1 mutation
Glioma
IDH2 mutation
Glioma
HER-2 expression
Breast Cancer
PTEN overexpression
SCCHN
BRAF V600
CRC
HER-2 positive
CRC
MSI-H/dMMR
Endometrial Cancer
PD-L1 expression
Cervical Cancer
EGFR mutation
NSCLC
HRD
Prostate Cancer
HR positive
HER2 Negative Breast Cancer
ER positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
HR positive
HER2 Negative Breast Cancer
PD-L1 expression
NSCLC
KRAS G12C
NSCLC
KRAS G12C
NSCLC
FGFR2-BICC1 fusion
Cholangiocarcinoma
EGFR negative
Lung Non-Squamous Non-Small Cell Cancer
EGFR L858R
NSCLC
EGFR exon 19 deletion
NSCLC
EGFR T790M
LUAD
BRAF mutation
Melanoma
EGFR mutation
NSCLC
RET rearrangement
NSCLC
LDH elevation
RCC